63 related articles for article (PubMed ID: 12193275)
1. Identification of Ewing's sarcoma gene product as a glycoprotein using a monoclonal antibody that recognizes an immunodeterminant containing O-linked N-acetylglucosamine moiety.
Matsuoka Y; Matsuoka Y; Shibata S; Yasuhara N; Yoneda Y
Hybrid Hybridomics; 2002 Aug; 21(4):233-6. PubMed ID: 12193275
[TBL] [Abstract][Full Text] [Related]
2. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
Peng W; Huang X; Yang D
Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
[TBL] [Abstract][Full Text] [Related]
3. Prediction and identification of B cell epitopes derived from EWS/FLI-l fusion protein of Ewing's sarcoma.
Liu H; Huang L; Luo J; Chen W; Zhang Z; Liao X; Dai M; Shu Y; Cao K
Med Oncol; 2012 Dec; 29(5):3421-30. PubMed ID: 22562156
[TBL] [Abstract][Full Text] [Related]
4. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
5. Ewing's sarcoma: analysis of single nucleotide polymorphism in the EWS gene.
Silva DS; Sawitzki FR; De Toni EC; Graebin P; Picanco JB; Abujamra AL; de Farias CB; Roesler R; Brunetto AL; Alho CS
Gene; 2012 Nov; 509(2):263-6. PubMed ID: 22925827
[TBL] [Abstract][Full Text] [Related]
6. Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and RNA-binding protein.
Takahama K; Kino K; Arai S; Kurokawa R; Oyoshi T
FEBS J; 2011 Apr; 278(6):988-98. PubMed ID: 21244633
[TBL] [Abstract][Full Text] [Related]
7. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
[TBL] [Abstract][Full Text] [Related]
8. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
[TBL] [Abstract][Full Text] [Related]
9. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
[TBL] [Abstract][Full Text] [Related]
10. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
11. EWS represses cofilin 1 expression by inducing nuclear retention of cofilin 1 mRNA.
Huang L; Kuwahara I; Matsumoto K
Oncogene; 2014 Jun; 33(23):2995-3003. PubMed ID: 23831569
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.
Kamemura K
Biosci Biotechnol Biochem; 2017 Mar; 81(3):541-546. PubMed ID: 27903134
[TBL] [Abstract][Full Text] [Related]
13. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
14. Identification of a self-association domain in the Ewing's sarcoma protein: a novel function for arginine-glycine-glycine rich motifs?
Shaw DJ; Morse R; Todd AG; Eggleton P; Lorson CL; Young PJ
J Biochem; 2010 Jun; 147(6):885-93. PubMed ID: 20211855
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
Fukuma M; Okita H; Hata J; Umezawa A
Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
[TBL] [Abstract][Full Text] [Related]
16. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
[TBL] [Abstract][Full Text] [Related]
17. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation by the Ewing's sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain.
Li KK; Lee KA
J Biol Chem; 2000 Jul; 275(30):23053-8. PubMed ID: 10767297
[TBL] [Abstract][Full Text] [Related]
19. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
[TBL] [Abstract][Full Text] [Related]
20. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
